Surgical Science Sweden AB

Equities

SUS

SE0014428512

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm 11:29:33 2024-04-24 am EDT 5-day change 1st Jan Change
149.9 SEK -0.73% Intraday chart for Surgical Science Sweden AB +1.77% -17.86%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Gisli Hennermark to Leave His Position as CEO of Surgical Science Sweden AB CI
Surgical Science Sweden to Step Down; Search for Successor Starts MT
Gisli Hennermark Intends to Leave as CEO of Surgical Science Sweden AB CI
Transcript : Surgical Science Sweden AB, 2023 Earnings Call, Feb 21, 2024
Surgical Science Sweden AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
Global markets live: J Sainsbury, Intel, Tesla, Boeing, Amazon... Our Logo
In wait-and-see mode Our Logo
Transcript : Surgical Science Sweden AB, Q3 2023 Earnings Call, Nov 09, 2023
Surgical Science Sweden AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Surgical Science Sweden AB Announces Appointments to its Nomination Committee CI
Berenberg Begins Surgical Science Sweden’s Coverage at Buy MT
Nordic Stocks Decreased Friday; Surgical Science Sweden Fell Furthest DJ
Nordic Stocks Closed Down Thursday; Surgical Science Sweden Posted Biggest Loss DJ
Surgical Science Sweden AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Nordic Shares Closed Down Thursday; Crayon Group Posted Biggest Loss DJ
Surgical Science Sweden AB Approves Election of Åsa Bredin as Board Member CI
Surgical Science Sweden AB Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Surgical Science Sweden AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
Surgical Science Sweden AB Reports Earnings Results for the Full Year Ended December 31, 2022 CI
The American Society for Gastrointestinal Endoscopy and Surgical Science to Jointly Developes New Gi Endoscopic Simulation-Based Curricula CI
Surgical Science Sweden AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Surgical Science Sweden AB(OM:SUS) added to S&P Global BMI Index CI
Surgical Science Sweden AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Surgical Science Sweden AB Receives Order of Approximately SEK 66 Million CI
Surgical Science Sweden AB Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Chart Surgical Science Sweden AB
More charts
Surgical Science Sweden AB is a Sweden-based company, which provides with virtual reality simulators for evidence based laparoscopic and endoscopic training. The systems comprise LapSim, EndoSim and TeamSim trainings. Each training combine graphics and cognitive instruction, imply navigation on touch screens and feature tactile feedback technology. The LapSim trainings consist of laparoscopic exercises that range from basic navigation to advanced suturing, the EndoSim endoscopic exercises range from functions of the scope handle and tube, to loop reduction. The TeamSim comprises procedure modules to train in a real world operation room environment and helps to build team communication skills in crisis and routine situations. The training systems are used by medical training centers and institutes worldwide for practice, validation and certification of students, surgeons, and medical doctors.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
151 SEK
Average target price
221.5 SEK
Spread / Average Target
+46.69%
Consensus
  1. Stock Market
  2. Equities
  3. SUS Stock
  4. News Surgical Science Sweden AB
  5. Surgical Science Sweden : Completes Acquisition Of Simbionix USA